TNDM Tandem Diabetes Care margins

?
Relative Growth: Rel. Growth: 53
Relative Strength: Rel. Strength: 54
Relative Valuation: Rel. Valuation: 27
Relative Profitability: Rel. Profitability: 40
Gross margin
56%
Operating margin
-4.4%
EBITDA margin
-3.3%
Net margin
-6.1%

Tandem Diabetes Care reports its operating margin is negative at -4.4%, its EBITDA margin is negative at -3.3%, and its net margin is negative at -6.1%, alongside a gross margin of 56%, an operating margin of -4.4%, an EBITDA margin of -3.3%, and a net margin of -6.1%. Operating margin had the largest improvement, increasing by 15.5 percentage points, while the other available margins also improved.

TNDM margin history

Gross, operating, EBITDA and net margin trends

Looking back over the last 3 years, Tandem Diabetes Care recorded average margins of 52.01% gross, -16.59% operating, -13.69% EBITDA, and -16.84% net. Compared with their three-year averages, all four current margins are higher.

TNDM margin expansion

Year-over-year margin changes in percentage points

Year over year, gross, operating, EBITDA, and net margins all increased, with operating margin showing the largest gain at 15.5 percentage points.

Gross margin expansion
3.5pp
Operating margin expansion
15.5pp
EBITDA margin expansion
14.4pp
Net margin expansion
14.4pp

TNDM Gross margin

The average gross margin for Tandem Diabetes Care was 52.01% during the last 3 years. At present, the current gross margin for Tandem Diabetes Care is 56%, 4 percentage points above its three-year average. The gross margin for Tandem Diabetes Care moved between 49.1% in Jun 2024 and 56% in Jun 2026.

TNDM Operating margin

Across the last 3 years, Tandem Diabetes Care's operating margin stood at -16.59%. Against its three-year average, Tandem Diabetes Care's operating margin is currently -4.4%, 12.2 percentage points above its three-year average. Operating margin was highest at -4.4% in Jun 2026 and lowest at -31.2% in Dec 2023.

TNDM EBITDA margin

Tandem Diabetes Care's EBITDA margin averaged -13.69% across the past 3 years. Compared with its three-year average, Tandem Diabetes Care's current EBITDA margin is -3.3% and is 10.4 percentage points above its three-year average. Over the last 3 years, Tandem Diabetes Care's EBITDA margin peaked at -3.3% in Jun 2026 and reached a low of -26% in Dec 2023.

TNDM Net margin

Tandem Diabetes Care recorded an average net margin of -16.84% across the last 3 years. Tandem Diabetes Care currently reports a net margin of -6.1%, 10.7 percentage points above its three-year average. Over the last 3 years, Tandem Diabetes Care's net margin peaked at -6.1% in Jun 2026 and reached a low of -29.8% in Dec 2023.

TNDM margin group comparison

Margins compared with peer-group, industry and sector averages

Tandem Diabetes Care's gross margin of 56% is below the Healthcare sector, the industry and its peers average. Compared to its Healthcare sector average of 68.4%, Tandem Diabetes Care's gross margin is 18% lower.

TNDM margin peer comparison

Compare margins with selected peers

Frequently asked questions

What is Tandem Diabetes Care's gross margin?

As of Jun 30, 2026, TNDM has a gross margin of 56%.

What is Tandem Diabetes Care's operating margin?

The current operating margin for TNDM is -4.4% as of Jun 30, 2026.

What is Tandem Diabetes Care's EBITDA margin?

For the period ending Jun 30, 2026, TNDM recorded an EBITDA margin of -3.3%.

What is Tandem Diabetes Care's net margin?

As of Jun 30, 2026, TNDM has a net margin of -6.1%.

What are the average margins of TNDM?

Over the last 3 years, Tandem Diabetes Care's margins averaged 52.0% gross, -16.6% operating, -13.7% EBITDA, and -16.8% net.

What are the highest historical margins of TNDM?

Tandem Diabetes Care's highest recorded margins during the past 5 years were 56% gross in Jun 2026, 3.2% operating in Dec 2021, 5.1% EBITDA in Dec 2021, and 2.2% net in Dec 2021.

What are the lowest historical margins of TNDM?

Tandem Diabetes Care's lowest recorded margins during the past 5 years were 49.1% gross in Jun 2024, -31.2% operating in Dec 2023, -26% EBITDA in Dec 2023, and -29.8% net in Dec 2023.